Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Arthur D Clark

Showing results (1-10 of 16) with videos related to

Pageof 2
Sort By:
Structure (London, England : 1993)|April 6, 2004
Crystal structures of arginine deiminase with covalent reaction intermediates; implications for catalytic mechanismKalyan Das, Gary H Butler, Victoria Kwiatkowski, et al.
Journal of Molecular Biology|October 24, 2006
Crystal structures of clinically relevant Lys103Asn/Tyr181Cys double mutant HIV-1 reverse transcriptase in complexes with ATP and non-nucleoside inhibitor HBY 097Kalyan Das, Stefan G Sarafianos, Arthur D Clark, et al.
Journal of Medicinal Chemistry|March 31, 2011
Crystal structure of tert-butyldimethylsilyl-spiroaminooxathioledioxide-thymine (TSAO-T) in complex with HIV-1 reverse transcriptase (RT) redefines the elastic limits of the non-nucleoside inhibitor-binding pocketKalyan Das, Joseph D Bauman, Angela S Rim, et al.
Journal of Medicinal Chemistry|March 18, 2005
Concentration and pH dependent aggregation of hydrophobic drug molecules and relevance to oral bioavailabilityYulia Volovik Frenkel, Arthur D Clark, Kalyan Das, et al.
Proceedings of the National Academy of Sciences of the United States of America|January 31, 2008
High-resolution structures of HIV-1 reverse transcriptase/TMC278 complexes: strategic flexibility explains potency against resistance mutationsKalyan Das, Joseph D Bauman, Arthur D Clark, et al.
Nucleic Acids Research|August 5, 2008
Crystal engineering of HIV-1 reverse transcriptase for structure-based drug designJoseph D Bauman, Kalyan Das, William C Ho, et al.
The EMBO Journal|November 29, 2002
Structures of HIV-1 reverse transcriptase with pre- and post-translocation AZTMP-terminated DNAStefan G Sarafianos, Arthur D Clark, Kalyan Das, et al.
Nature Structural & Molecular Biology|September 21, 2010
Structural basis of HIV-1 resistance to AZT by excisionXiongying Tu, Kalyan Das, Qianwei Han, et al.
Structure (London, England : 1993)|December 17, 2009
Structure of HIV-1 reverse transcriptase with the inhibitor beta-Thujaplicinol bound at the RNase H active siteDaniel M Himmel, Karen A Maegley, Tom A Pauly, et al.
Journal of Medicinal Chemistry|November 24, 2005
Crystal structures for HIV-1 reverse transcriptase in complexes with three pyridinone derivatives: a new class of non-nucleoside inhibitors effective against a broad range of drug-resistant strainsDaniel M Himmel, Kalyan Das, Arthur D Clark, et al.
Pageof 2

Showing results (1-10 of 16) with videos related to

Sort By:
Pageof 2
Structure (London, England : 1993)|April 6, 2004
Crystal structures of arginine deiminase with covalent reaction intermediates; implications for catalytic mechanismKalyan Das, Gary H Butler, Victoria Kwiatkowski, et al.
Journal of Molecular Biology|October 24, 2006
Crystal structures of clinically relevant Lys103Asn/Tyr181Cys double mutant HIV-1 reverse transcriptase in complexes with ATP and non-nucleoside inhibitor HBY 097Kalyan Das, Stefan G Sarafianos, Arthur D Clark, et al.
Journal of Medicinal Chemistry|March 31, 2011
Crystal structure of tert-butyldimethylsilyl-spiroaminooxathioledioxide-thymine (TSAO-T) in complex with HIV-1 reverse transcriptase (RT) redefines the elastic limits of the non-nucleoside inhibitor-binding pocketKalyan Das, Joseph D Bauman, Angela S Rim, et al.
Journal of Medicinal Chemistry|March 18, 2005
Concentration and pH dependent aggregation of hydrophobic drug molecules and relevance to oral bioavailabilityYulia Volovik Frenkel, Arthur D Clark, Kalyan Das, et al.
Proceedings of the National Academy of Sciences of the United States of America|January 31, 2008
High-resolution structures of HIV-1 reverse transcriptase/TMC278 complexes: strategic flexibility explains potency against resistance mutationsKalyan Das, Joseph D Bauman, Arthur D Clark, et al.
Nucleic Acids Research|August 5, 2008
Crystal engineering of HIV-1 reverse transcriptase for structure-based drug designJoseph D Bauman, Kalyan Das, William C Ho, et al.
The EMBO Journal|November 29, 2002
Structures of HIV-1 reverse transcriptase with pre- and post-translocation AZTMP-terminated DNAStefan G Sarafianos, Arthur D Clark, Kalyan Das, et al.
Nature Structural & Molecular Biology|September 21, 2010
Structural basis of HIV-1 resistance to AZT by excisionXiongying Tu, Kalyan Das, Qianwei Han, et al.
Structure (London, England : 1993)|December 17, 2009
Structure of HIV-1 reverse transcriptase with the inhibitor beta-Thujaplicinol bound at the RNase H active siteDaniel M Himmel, Karen A Maegley, Tom A Pauly, et al.
Journal of Medicinal Chemistry|November 24, 2005
Crystal structures for HIV-1 reverse transcriptase in complexes with three pyridinone derivatives: a new class of non-nucleoside inhibitors effective against a broad range of drug-resistant strainsDaniel M Himmel, Kalyan Das, Arthur D Clark, et al.
Pageof 2